Ayala Pharmaceuticals Stock Price, News & Analysis
Company Description
Ayala Pharmaceuticals (NASDAQ: AYLA) is a publicly traded biological product (except diagnostic) manufacturing company in the Manufacturing sector. The company has a market capitalization of $7.9M.
AYLA stock has declined 92.6% over the past year.
This page provides a comprehensive overview of AYLA stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Ayala Pharmaceuticals (AYLA) stock. Over the past 12 months, the stock has lost 92.6%. At a market capitalization of $7.9M, AYLA is classified as a micro-cap stock with approximately 14.8M shares outstanding.
Latest News
Ayala Pharmaceuticals has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 7 with negative movement. Key topics include clinical trial, earnings, acquisition, conferences, fda approval. View all AYLA news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
AYLA Company Profile & Sector Positioning
Ayala Pharmaceuticals (AYLA) operates in the Biological Product (except Diagnostic) Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.